SEMA6D and malignant pleural mesothelioma: Catalano et al. demonstrated that binding of Semaphorin 6D (Sema6D) to its receptor, Plexin-A1, triggered NF-κB transcriptional activity that supported a pro-survival program in malignant pleural mesothelioma cells [33].